Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)

Due to the morbidity and mortality of meningococcal disease, the Advisory Committee of Immunization Practices recommended in 2007 immunization of all children 11–18 years old with a protein-conjugated meningococcal vaccine. There is limited data on the immunogenicity of this vaccine following alloHC...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Mahler, Michelle B., Taur, Ying, Jean, Raymond, Kernan, Nancy A, Prockop, Susan E, Small, Trudy N.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2011
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286795/
https://ncbi.nlm.nih.gov/pubmed/21820392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.027
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια